Kenneth Harrison


Kenneth Harrison, Ph.D., serves as a member of our board of directors and joined Novo Ventures (US) Inc. in San Francisco, California in 2015. Dr. Harrison currently serves on the boards of Glycomine and Aristea Therapeutics, and while at Novo has been involved with investments in Bolt Biotherapeutics, Mirum Pharma (NASDAQ: MIRM) and ViewPoint T...

Roles at Edgewise Therapeutics

  • Director

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.